Variant report
Variant | esv3404369 |
---|---|
Chromosome Location | chr6:63339143-63341141 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184601766 | chr6:63340465-63340466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534621868 | chr6:63340474-63340475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373816579 | chr6:63340496-63340497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546726865 | chr6:63340548-63340549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs117625128 | chr6:63340552-63340553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536741351 | chr6:63340579-63340580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201634721 | chr6:63340652-63340653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368852876 | chr6:63340657-63340658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73500890 | chr6:63340662-63340663 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs34081379 | chr6:63340682-63340683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577942189 | chr6:63340691-63340692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187433850 | chr6:63340706-63340707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577427982 | chr6:63340709-63340710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2782376 | chr6:63340759-63340760 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs527291313 | chr6:63340788-63340789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574976225 | chr6:63340838-63340839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs59360373 | chr6:63340945-63340946 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs545830494 | chr6:63340950-63340951 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530637026 | chr6:63340982-63340983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545774975 | chr6:63340984-63340985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148021622 | chr6:63341011-63341012 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528384078 | chr6:63341040-63341041 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2843040 | chr6:63341061-63341062 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs568231734 | chr6:63341071-63341072 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529082111 | chr6:63341077-63341078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375786674 | chr6:63341095-63341096 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Schizophrenia | 23813976 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:63340400-63341200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr6:63340600-63340800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr6:63340600-63340800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr6:63340600-63341000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:63340600-63341200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr6:63340800-63341200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr6:63340800-63341800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
8 | chr6:63340800-63341800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
9 | chr6:63341000-63342000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |